SUST Repository

Quality Assurance of Technitium99m Labelled Radiopharmaceuticals in the Radiation and Isotopes Centre of Khartoum RICK

Show simple item record

dc.contributor.author Adlan, Awad Abdalla
dc.contributor.author Supervisor-Othman Mustafa Mukhtar
dc.date.accessioned 2015-02-05T12:43:05Z
dc.date.available 2015-02-05T12:43:05Z
dc.date.issued 2007-01-01
dc.identifier.citation Adlan , Awad Abdalla . Quality Assurance of Technitium99m Labelled Radiopharmaceuticals in the Radiation and Isotopes Centre of KhartoumRICK / Awad Abdalla Adlan ; Othman Mustafa Mukhtar .- Khartoum : Sudan University of Science and Technology , Medical Radiologic, 2014.- 196p. : ill . ; 28cm .-M.Sc. en_US
dc.identifier.uri http://repository.sustech.edu/handle/123456789/10320
dc.description Thesis en_US
dc.description.abstract The researcher aims to study the amount of contrast media dose which is given to the patients who are investigated by MRI. The researcher assume that the dose of C.M is not given as the recommended dose from the manufacture that give every weight its suitable dose. This research was done in Medical Salvation Center and Khartoum Advance Development Center. The researcher use the questionnaire to collect the data from (100) random sample (51F, 49 M) will different sexes, ages and weights and the results were as following:-  Only 3% of the patients were injected with suitable dose according to their weight and the resolution of the images was good and well diagnosed.  13% of the patient, took an amount of dose more than the recommended dose, the images were clear with good resolution and no side effects were happened during the examination.  84% of the patients who were the majority took an amount of dose less than the recommended dose and the absorption of the contrast differ according to the alternative disease and the results were as the following:- V o 20% of the patients have got good absorption inspite of the recommended dose. o 22% of the patients have got intermediate absorption. o 40% of the patients have got low absorption. o 18% of the patients have got no absorption. The reduction of C.M dose lead to misdiagnosis in some cases and repetition of others and then increase the cost to the patient. The main causes that lead to these results that the absence of proper instrument to weight the patient so as to give the ideal dose and also the too expensive C.M. No serious side effects were happened from using C.M except in two cases only mild vomiting was happened because the patients weren’t fasting. Finally, the researcher found that the research hypotheses were correct and this center did not give the patients the ideal and suitable doses. The researcher recommended to give the company detected dose according to the patient weight to gain the correct diagnosis. en_US
dc.description.sponsorship Sudan University of Science and Technology en_US
dc.language.iso other en_US
dc.publisher Sudan University of Science and Technology en_US
dc.subject Diagnostic Radiological Technology en_US
dc.subject Nuclear Medicine Technology en_US
dc.subject Quality Assurance en_US
dc.subject Technitium99m-Labelled en_US
dc.subject Radiopharmaceuticals en_US
dc.title Quality Assurance of Technitium99m Labelled Radiopharmaceuticals in the Radiation and Isotopes Centre of Khartoum RICK en_US
dc.title.alternative تأكيد الجودة للمستحضرات الإشعاعية الصيدلانية المرقومة بالتكنيشيوم-99m بالمركز القومي للعلاج بالأشعة والطب النووي بالخرطوم en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Share

Search SUST


Browse

My Account